$3.05
-0.03-0.97%
Pre-Market: 8:40 AM EDT
Comments
Loading...
Aclaris Therapeutics (ACRS) Forecast
NewsEarningsAclaris Therapeutics (ACRS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAclaris Therapeutics (NASDAQ:ACRS) Stock Quotes, Forecast and News Summary
Aclaris Therapeutics Stock (NASDAQ: ACRS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aclaris Therapeutics (ACRS) stock?
You can purchase shares of Aclaris Therapeutics (NASDAQ:ACRS) through any online brokerage.
Who are Aclaris Therapeutics (ACRS) competitors?
Other companies in Aclaris Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), GH Research (NASDAQ:GHRS), Bioage Labs (NASDAQ:BIOA), Aquestive Therapeutics (NASDAQ:AQST) and Telomir Pharmaceuticals (NASDAQ:TELO).
What is the forecast, or price target, for Aclaris Therapeutics (ACRS) stock?
Aclaris Therapeutics has a consensus price target of $11.29.
What is the current price for Aclaris Therapeutics (ACRS)?
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $3.05 last updated December 19, 2024 at 8:40 AM EST.
Does Aclaris Therapeutics (ACRS) pay a dividend?
There are no upcoming dividends for Aclaris Therapeutics.
When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?
Aclaris Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Aclaris Therapeutics (ACRS) going to split?
There is no upcoming split for Aclaris Therapeutics.
What sector and industry does Aclaris Therapeutics (ACRS) operate in?
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.